{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:29:44Z","timestamp":1779114584816,"version":"3.51.4"},"reference-count":113,"publisher":"Elsevier","isbn-type":[{"value":"9780443295485","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["\/2024\/215"],"award-info":[{"award-number":["\/2024\/215"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.vh.2024.10.002","type":"book-chapter","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:54:17Z","timestamp":1730271257000},"page":"1-59","source":"Crossref","is-referenced-by-count":2,"title":["Targeting steroid hormone receptors for anti-cancer therapy"],"prefix":"10.1016","member":"78","reference":[{"issue":"19","key":"10.1016\/bs.vh.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2217\/nnm-2016-0224","article-title":"Glucocorticoid receptor-mediated delivery of nano gold\u2013withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression","volume":"11","author":"Agarwalla","year":"2016","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jsps.2019.03.005","article-title":"Evaluation of the in vivo genotoxicity of liposomal formulation for delivering anticancer estrogenic derivative (ESC8) in a mouse model","volume":"27","author":"Ahmad","year":"2019","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.09.008","article-title":"Steroid hormone receptors in cancer development: A target for cancer therapeutics","volume":"300","author":"Ahmad","year":"2011","journal-title":"Cancer Letters"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acs.molpharmaceut.5b00900","article-title":"Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model","volume":"13","author":"Ahmad","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"01","DOI":"10.33545\/26174693.2024.v8.i5a.1048","article-title":"The study of chemical reactions in the human body through the use of hormones","volume":"8","author":"Aldhalemi","year":"2024","journal-title":"International Journal of Advanced Biochemistry Research"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand","year":"2008","journal-title":"Pharmaceutical Research"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/mp5008629","article-title":"Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: Pharmacokinetic and efficacy evaluation","volume":"12","author":"Andey","year":"2015","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","article-title":"Targeted cancer therapy: The next generation of cancer treatment","volume":"12","author":"Baudino","year":"2015","journal-title":"Current Drug Discovery Technologies"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.biocel.2009.11.013","article-title":"Molecular cell biology of androgen receptor signalling","volume":"42","author":"Bennett","year":"2010","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.vh.2024.10.002_bib10","series-title":"NeuroImmune biology","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1567-7443(03)80050-9","article-title":"Steroid hormones","author":"Berczi","year":"2003"},{"key":"10.1016\/bs.vh.2024.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107294","article-title":"Bis-arylidene oxindoles for colorectal cancer nanotherapy","volume":"146","author":"Bhattacharyya","year":"2024","journal-title":"Bioorganic Chemistry"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bj\u00f6rnstr\u00f6m","year":"2005","journal-title":"Molecular Endocrinology"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.002_bib13","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2024.10.002_bib15","doi-asserted-by":"crossref","unstructured":"Camacho-Arroyo, I., Hansberg-Pastor, V., V\u00e1zquez-Mart\u00ednez, E. R., & Cerb\u00f3n, M. (2017). Mechanism of progesterone action in the brain.","DOI":"10.1016\/B978-0-12-803592-4.00053-5"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.002_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"Carver","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/onc.2017.319","article-title":"Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors","volume":"37","author":"Chan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/bs.vh.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0971-9","article-title":"Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment","volume":"18","author":"Cheng","year":"2019","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.vh.2024.10.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2024.112846","article-title":"Glucocorticoid receptor mediated sensitization of colon cancer to photodynamic therapy induced cell death","volume":"251","author":"Chilakamarthi","year":"2024","journal-title":"Journal of Photochemistry and Photobiology B: Biology"},{"key":"10.1016\/bs.vh.2024.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2024.01.012","article-title":"Glucocorticoid receptor signaling: Intricacies and therapeutic opportunities","author":"Clarisse","year":"2024","journal-title":"Trends in Biochemical Sciences"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/cancers9060067","article-title":"Androgen receptor-dependent and-independent mechanisms involved in prostate cancer therapy resistance","volume":"9","author":"Crona","year":"2017","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1517\/14656566.2014.915313","article-title":"Targeting the androgen receptor in prostate cancer","volume":"15","author":"Culig","year":"2014","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/eem.11.25","article-title":"Progesterone receptor action: Defining a role in breast cancer","volume":"6","author":"Daniel","year":"2011","journal-title":"Expert Review of Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib24","first-page":"3","article-title":"Androgen receptor structure, function and biology: From bench to bedside","volume":"37","author":"Davey","year":"2016","journal-title":"The Clinical Biochemist Reviews"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/JOE-07-0317","article-title":"Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone","volume":"196","author":"Dosiou","year":"2008","journal-title":"Journal of Endocrinology"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.002_bib26","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1039\/C7BM00405B","article-title":"Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression","volume":"5","author":"Elechalawar","year":"2017","journal-title":"Biomaterials Science"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib27","article-title":"Basics of androgen synthesis and action","volume":"36","author":"Elzenaty","year":"2022","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"issue":"18","key":"10.1016\/bs.vh.2024.10.002_bib28","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/0008-5472.CAN-16-3541","article-title":"Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III","volume":"77","author":"Finlay-Schultz","year":"2017","journal-title":"Cancer Research"},{"issue":"26","key":"10.1016\/bs.vh.2024.10.002_bib29","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2009.27.4290","article-title":"Influence of sex hormones on cancer progression","volume":"28","author":"Folkerd","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002790","article-title":"Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton","volume":"3","author":"Fu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"5\u20136","key":"10.1016\/bs.vh.2024.10.002_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/1061186X.2018.1433679","article-title":"Oestrogen receptor-mediated liposomal drug delivery for treating melanoma","volume":"26","author":"Ganguly","year":"2018","journal-title":"Journal of Drug Targeting"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s42003-022-04251-6","article-title":"Protein structure determination in human cells by in-cell NMR and a reporter system to optimize protein delivery or transexpression","volume":"5","author":"Gerez","year":"2022","journal-title":"Communications Biology"},{"key":"10.1016\/bs.vh.2024.10.002_bib34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2741\/2088","article-title":"Progesterone receptor profile in the decidua and fetal membrane","volume":"12","author":"Goldman","year":"2007","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/bs.vh.2024.10.002_bib35","first-page":"965","article-title":"The multifaceted mineralocorticoid receptor","author":"Gomez-Sanchez","year":"2014","journal-title":"Comprehensive Physiology 4(3"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.002_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/bcr450","article-title":"Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells","volume":"4","author":"Graham","year":"2002","journal-title":"Breast Cancer Research: BCR"},{"key":"10.1016\/bs.vh.2024.10.002_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fcell.2016.00121","article-title":"Origin of cancer: An information, energy, and matter disease","volume":"4","author":"Hanselmann","year":"2016","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-020-0371-y","article-title":"Therapeutic glucocorticoids: Mechanisms of actions in rheumatic diseases","volume":"16","author":"Hardy","year":"2020","journal-title":"Nature Reviews Rheumatology"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2022.07.006","article-title":"Control of immunity and allergy by steroid hormones","volume":"71","author":"Ikuta","year":"2022","journal-title":"Allergology International"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/07853899309147863","article-title":"Androgen receptor and mechanism of androgen action","volume":"25","author":"J\u00e4nne","year":"1993","journal-title":"Annals of Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib41","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abdb08","article-title":"Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer","volume":"16","author":"Jinka","year":"2021","journal-title":"Biomedical Materials"},{"issue":"Suppl 1","key":"10.1016\/bs.vh.2024.10.002_bib42","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1177\/1071557600007001S10","article-title":"Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways","volume":"7","author":"Katzenellenbogen","year":"2000","journal-title":"The Journal of the Society for Gynecologic Investigation: JSGI"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2013.11.010","article-title":"Tracking progesterone receptor-mediated actions in breast cancer","volume":"142","author":"Knutson","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"issue":"14","key":"10.1016\/bs.vh.2024.10.002_bib44","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.3390\/ijms23147989","article-title":"Progesterone: A steroid with wide range of effects in physiology as well as human medicine","volume":"23","author":"Kolatorova","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.002_bib45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamaoncol.2016.4975","article-title":"Androgen receptor function and androgen receptor\u2013targeted therapies in breast cancer: A review","volume":"3","author":"Kono","year":"2017","journal-title":"JAMA Oncology"},{"key":"10.1016\/bs.vh.2024.10.002_bib46","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.87233","article-title":"Investigating the role of mineralocorticoid receptor signaling in cancer biology in the genomic era","author":"Konu","year":"2019","journal-title":"Aldosterone-Mineralocorticoid Receptor-Cell Biology to Translational Medicine"},{"issue":"19","key":"10.1016\/bs.vh.2024.10.002_bib47","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3390\/cancers13194779","article-title":"Steroid receptors in breast cancer: Understanding of molecular function as a basis for effective therapy development","volume":"13","author":"Kowalczyk","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/bs.vh.2024.10.002_bib48","doi-asserted-by":"crossref","unstructured":"Lanari, C. L. M., Wargon, V., Rojas, P. A., & Molinolo, A. (2012). Antiprogestins in breast cancer treatment: Are we ready?","DOI":"10.1530\/ERC-11-0378"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib49","doi-asserted-by":"crossref","first-page":"1800091","DOI":"10.1002\/adtp.201800091","article-title":"Advances in receptor-mediated, tumor\u2010targeted drug delivery","volume":"2","author":"Large","year":"2019","journal-title":"Advanced Therapeutics"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib50","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/en.2003-0732","article-title":"Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells","volume":"145","author":"Leo","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2024.10.002_bib51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.18632\/oncotarget.28191","article-title":"The long winding road to the safer glucocorticoid receptor (GR) targeting therapies","volume":"13","author":"Lesovaya","year":"2022","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.111.072249","article-title":"The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor \u03b1 and cyclin D1","volume":"80","author":"Lewis-Wambi","year":"2011","journal-title":"Molecular Pharmacology"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.002_bib53","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","article-title":"Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib54","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1039\/C8NJ04159H","article-title":"Enhancement of therapeutic effect in breast cancer with a steroid-conjugated ruthenium complex","volume":"43","author":"Lv","year":"2019","journal-title":"New Journal of Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib55","article-title":"Targeting steroid hormone receptors for anti\u2010cancer therapy\u2014A review on small molecules and nanotherapeutic approaches","volume":"14","author":"Mahadik","year":"2022","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/bs.vh.2024.10.002_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fendo.2012.00007","article-title":"Progesterone signaling mechanisms in brain and behavior","volume":"3","author":"Mani","year":"2012","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2024.10.002_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2015.06.028","article-title":"Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model","volume":"213","author":"Markov","year":"2015","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262485","article-title":"SERMs (selective estrogen receptor modulator), acting as estrogen receptor \u03b2 agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-\u03b1-induced migration via specific inhibition of AKT signaling pathway","volume":"17","author":"Matsushima-Nishiwaki","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib59","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.18632\/oncotarget.14894","article-title":"Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer","volume":"8","author":"McDermott","year":"2017","journal-title":"Oncotarget"},{"issue":"81","key":"10.1016\/bs.vh.2024.10.002_bib60","doi-asserted-by":"crossref","first-page":"77841","DOI":"10.1039\/C6RA07256A","article-title":"Asymmetric cationic lipid based non-viral vectors for an efficient nucleic acid delivery","volume":"6","author":"Meka","year":"2016","journal-title":"RSC Advances"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/10717540903271391","article-title":"Targeted delivery of an anti-cancer agent via steroid coupled liposomes","volume":"16","author":"Mishra","year":"2009","journal-title":"Drug Delivery"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.002_bib62","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrd4003","article-title":"Strategies for optimizing the response of cancer and normal tissues to radiation","volume":"12","author":"Moding","year":"2013","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7560","key":"10.1016\/bs.vh.2024.10.002_bib63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ER\u03b1 action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib64","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/acs.molpharmaceut.2c00887","article-title":"Progesterone-cationic lipid conjugate-based self-aggregates for cancer cell-selective uptake through macropinocytosis and the antitumour effect","volume":"20","author":"Mondal","year":"2023","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.vh.2024.10.002_bib65","article-title":"Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof","author":"Mondal","year":"2018","journal-title":"Google Patents"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.002_bib66","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acs.molpharmaceut.6b00230","article-title":"Glucocorticoid receptor-targeted liposomal codelivery of lipophilic drug and anti-Hsp90 gene: Strategy to induce drug-sensitivity, EMT-reversal, and reduced malignancy in aggressive tumors","volume":"13","author":"Mondal","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/cancers11081201","article-title":"Progesterone receptor B signaling reduces breast cancer cell aggressiveness: Role of cyclin-D1\/Cdk4 mediating paxillin phosphorylation","volume":"11","author":"Montalto","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/bs.vh.2024.10.002_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1200947","article-title":"Targeting nuclear hormone receptors for the prevention of breast cancer","volume":"10","author":"Moyer","year":"2023","journal-title":"Frontiers in Medicine"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/mt.2009.4","article-title":"Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor","volume":"17","author":"Mukherjee","year":"2009","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib70","doi-asserted-by":"crossref","first-page":"696","DOI":"10.62347\/MNYA9065","article-title":"Mineralocorticoid receptor signaling inhibits bladder cancer progression","volume":"14","author":"Nagata","year":"2024","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/bs.vh.2024.10.002_bib71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40487-017-0046-2","article-title":"A review of fulvestrant in breast cancer","volume":"5","author":"Nathan","year":"2017","journal-title":"Oncology and Therapy"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/proteomes10040035","article-title":"Proteomics-based identification of dysregulated proteins in breast cancer","volume":"10","author":"Neagu","year":"2022","journal-title":"Proteomes"},{"key":"10.1016\/bs.vh.2024.10.002_bib73","article-title":"Glucocorticoid receptor","author":"Nicolaides","year":"2020","journal-title":"Endotext [Internet]"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/cmdc.201400003","article-title":"Bis\u2010arylidene oxindoles as anti\u2010breast\u2010cancer agents acting via the estrogen receptor","volume":"9","author":"Pal","year":"2014","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib75","doi-asserted-by":"crossref","first-page":"F1065","DOI":"10.1152\/ajprenal.00147.2007","article-title":"Aldosterone promotes proximal tubular cell apoptosis: Role of oxidative stress","volume":"293","author":"Patni","year":"2007","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41374-021-00594-6","article-title":"Crosstalk between progesterone receptor membrane component 1 and estrogen receptor \u03b1 promotes breast cancer cell proliferation","volume":"101","author":"Pedroza","year":"2021","journal-title":"Laboratory Investigation"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib77","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1095\/biolreprod.104.031716","article-title":"Progesterone regulates granulosa cell viability through a protein kinase G-dependent mechanism that may involve 14-3-3\u03c3","volume":"71","author":"Peluso","year":"2004","journal-title":"Biology of reproduction"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.sbi.2005.01.008","article-title":"New methodologies for measuring protein interactions in vivo and in vitro","volume":"15","author":"Piehler","year":"2005","journal-title":"Current Opinion in Structural Biology"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.002_bib79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/JME-08-0093","article-title":"Structure-function relationships in the mineralocorticoid receptor","volume":"41","author":"Pippal","year":"2008","journal-title":"Journal of Molecular Endocrinology"},{"issue":"5804","key":"10.1016\/bs.vh.2024.10.002_bib80","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1126\/science.1130471","article-title":"Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist","volume":"314","author":"Poole","year":"2006","journal-title":"Science"},{"issue":"28","key":"10.1016\/bs.vh.2024.10.002_bib81","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1016\/j.biomaterials.2013.05.054","article-title":"Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect","volume":"34","author":"Pore","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/bs.vh.2024.10.002_bib82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijbiomac.2020.02.172","article-title":"Magnetic casein-CaFe2O4 nanohybrid carrier conjugated with progesterone for enhanced cytotoxicity of citrus peel derived hesperidin drug towards breast and ovarian cancer","volume":"151","author":"Purushothaman","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: Mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheumatic Disease Clinics"},{"key":"10.1016\/bs.vh.2024.10.002_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejmech.2015.11.033","article-title":"Cationic lipid-conjugated hydrocortisone as selective antitumor agent","volume":"108","author":"Rathore","year":"2016","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"41","key":"10.1016\/bs.vh.2024.10.002_bib85","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1002\/ange.200501793","article-title":"17\u03b2\u2010Estradiol\u2010associated stealth\u2010liposomal delivery of anticancer gene to breast cancer cells","volume":"117","author":"Reddy","year":"2005","journal-title":"Angewandte Chemie"},{"issue":"13","key":"10.1016\/bs.vh.2024.10.002_bib86","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/acs.jmedchem.3c00136","article-title":"Targeting the estrogen receptor for the treatment of breast cancer: Recent advances and challenges","volume":"66","author":"Rej","year":"2023","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib87","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/mp2000346","article-title":"17\u03b2-estradiol-linked nitro-L-arginine as simultaneous inducer of apoptosis in melanoma and tumor-angiogenic vascular endothelial cells","volume":"8","author":"Roy","year":"2011","journal-title":"Molecular Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.002_bib88","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1039\/c4nr00974f","article-title":"Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle","volume":"6","author":"Sau","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/bs.vh.2024.10.002_bib89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2014.06.051","article-title":"Cationic lipid-conjugated dexamethasone as a selective antitumor agent","volume":"83","author":"Sau","year":"2014","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.vh.2024.10.002_bib90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-017-3084-z","article-title":"Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: A strategy for repurposing a phase I clinical trial drug","volume":"436","author":"Sau","year":"2017","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib91","doi-asserted-by":"crossref","first-page":"a016709","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"13","key":"10.1016\/bs.vh.2024.10.002_bib92","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.addr.2010.08.001","article-title":"Selectively targeting estrogen receptors for cancer treatment","volume":"62","author":"Shanle","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.002_bib93","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbamem.2015.11.023","article-title":"Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells","volume":"1858","author":"Sharma","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/bs.vh.2024.10.002_bib94","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3389\/fimmu.2020.02143","article-title":"Glucocorticoids regulate circadian rhythm of innate and adaptive immunity","volume":"11","author":"Shimba","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib95","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/1541-7786.MCR-10-0526","article-title":"A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis","volume":"9","author":"Sinha","year":"2011","journal-title":"Molecular Cancer Research"},{"key":"10.1016\/bs.vh.2024.10.002_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101957","article-title":"Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes","volume":"45","author":"Snijesh","year":"2024","journal-title":"Translational Oncology"},{"key":"10.1016\/bs.vh.2024.10.002_bib97","first-page":"3","article-title":"Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs), Seminars in Reproductive Medicine, Copyright\u00a9 2005 by Thieme Medical Publishers, Inc","volume":"333","author":"Spitz","year":"2005","journal-title":"Seventh Avenue, New"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib98","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acs.molpharmaceut.0c01091","article-title":"Self-assembling derivative of hydrocortisone as glucocorticoid receptor-targeted nanotherapeutics for synergistic, combination therapy against colorectal tumor","volume":"18","author":"Sridharan","year":"2020","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.vh.2024.10.002_bib99","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ejmech.2014.09.030","article-title":"Development of new estradiol-cationic lipid hybrids: Ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity","volume":"86","author":"Sudhakar","year":"2014","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: Structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacologica Sinica"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.002_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200650","article-title":"Etoposide-entrapped progesterone-cationic lipid nanoaggregates as selective therapeutics against etoposide-resistant colorectal cancer cells","volume":"24","author":"Tanveer Ahmed","year":"2023","journal-title":"Chembiochem: A European Journal of Chemical Biology"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.002_bib102","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13046-019-1443-1","article-title":"Recent advances in nanotheranostics for triple negative breast cancer treatment","volume":"38","author":"Thakur","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.002_bib103","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tem.2015.08.002","article-title":"Progesterone receptor-estrogen receptor crosstalk: A novel insight","volume":"26","author":"Thomas","year":"2015","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059410","article-title":"The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer","volume":"8","author":"Tiberio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2024.10.002_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01545","article-title":"A general introduction to glucocorticoid biology","volume":"10","author":"Timmermans","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib106","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.002_bib107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5492\/wjccm.v10.i4.102","article-title":"Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review","volume":"10","author":"Vassiliou","year":"2021","journal-title":"World Journal of Critical Care Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.002_bib108","doi-asserted-by":"crossref","first-page":"329","DOI":"10.11613\/BM.2014.035","article-title":"The many faces of estrogen signaling","volume":"24","author":"Vrta\u010dnik","year":"2014","journal-title":"Biochemia Medica"},{"key":"10.1016\/bs.vh.2024.10.002_bib109","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1387\/ijdb.140069mw","article-title":"Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus","volume":"58","author":"Wetendorf","year":"2014","journal-title":"The International Journal of Developmental Biology"},{"key":"10.1016\/bs.vh.2024.10.002_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103719","article-title":"Methoxy-enriched cationic stilbenes as anticancer therapeutics","volume":"98","author":"Yousuf","year":"2020","journal-title":"Bioorganic Chemistry"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.002_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086992","article-title":"Progesterone resistance in endometriosis: Current evidence and putative mechanisms","volume":"24","author":"Zhang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"10.1016\/bs.vh.2024.10.002_bib112","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1074\/jbc.M501261200","article-title":"A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells","volume":"280","author":"Zheng","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.002_bib113","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1073\/pnas.0336132100","article-title":"Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes","volume":"100","author":"Zhu","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["Vitamins and Hormones","Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T16:24:49Z","timestamp":1755015889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672924000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443295485"],"references-count":113,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2024.10.002","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}